港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

英派藥業-B

13.020

+0.0700.54%

成交量：617.86萬

成交額：8,436.49萬

市值：36.78億

市盈率：-10.06

高：14.500

開：13.290

低：12.820

收：12.950

52周最高：47.980

52周最低：10.310

股本：2.82億

香港流通股本：2.82億

量比：2.25

換手率：2.19%

股息：- -

股息率：- -

每股收益(LYR):-1.295

淨資產收益率：--

總資產收益率：-40.35%

市淨率：4.04

市盈率(LYR):-10.06

市銷率: 26.49

資料載入中...

總覽公司新聞資訊公告

英派藥業-B：塞納帕利提交歐盟委員會，等待最終上市許可裁決

英派藥業與Pharmanovia宣佈：Senaparib獲歐洲藥監局人用藥品委員會積極意見，有望成為晚期高級別上皮性卵巢癌、輸卵管癌及原發性腹膜癌的一線維持治療新選擇

港股午評|恒生指數早盤漲0.67% AI製藥板塊大漲

英派藥業-B早盤升逾20% 近期入通並獲高管增持公司普通股

港股異動 | 英派藥業-B(07630.HK)早盤升逾25% 近期入通並獲高管增持核心產品塞納帕利加速放量

英派藥業－Ｂ(07630)股價上升8.156%，現價港幣$12.2

阿斯达克财经

英派藥業-B（07630）曾升逾20% 上周納入港股通中期營收增長超3倍

英派藥業－Ｂ(07630)股價大幅上升20.853%，現價港幣$15.59

阿斯达克财经

港股異動 | 英派藥業-B(07630.HK)尾盤升逾20% 公司本周進入港股通名單塞納帕利入醫保後快速放量

英派藥業－Ｂ(07630)股價大幅上升17.9%，現價港幣$13.7

阿斯达克财经

英派藥業－Ｂ(07630)股價下跌5.024%，現價港幣$11.91

阿斯达克财经

英派藥業-B(07630)獲納入滬港通及深港通證券名單

英派藥業-B（07630）H股納入滬深港通合資格名單將於2026年9月7日生效

英派藥業(07630)正式納入港股通打開內地投資者參與通道

英派藥業-B發布2026年8月股份變動月報表，股本保持穩定

英派藥業-B：蔡遂雄增持，好倉比例升至6.56%

港股異動 | 英派藥業-B(07630)漲近13% 核心產品塞納帕利快速放量獲納入恒生綜指有望入通

英派藥業(07630.HK)首席執行官斥逾146萬元增持10萬股

阿斯达克财经

英派藥業-B(07630.HK)獲執行董事兼首席執行官蔡遂雄增持10萬股

英派藥業-B（07630）CEO蔡遂雄增持10萬股持股比例升至6.564%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/07630/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"英派藥業-B","latestPrice":13.02,"timestamp":1792138094538,"preClose":12.95,"halted":0,"volume":6178600,"delay":0,"changeRate":0.005405405405405427,"floatShares":282461530,"shares":282461530,"eps":-1.294715,"marketStatus":"重陽節翌日休市","change":0.07,"latestTime":"10-16 16:08:14","open":13.29,"high":14.5,"low":12.82,"amount":84364938,"amplitude":0.12973,"askPrice":13.02,"askSize":3400,"bidPrice":12.97,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-1.052,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":7,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":12.95,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":2.2529243603096694,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","floatShares":282461530,"roa":"-40.35%","roe":"--","lyrEps":-1.294715,"volumeRatio":2.2529243603096694,"shares":282461530,"dividePrice":0,"high":14.5,"amplitude":0.12973,"preClose":12.95,"low":12.82,"week52Low":10.31,"pbRate":"4.04","psRate":"26.49","week52High":47.98,"institutionHeld":0,"latestPrice":13.02,"committee":-0.888889,"eps":-1.294715,"divideRate":0,"volume":6178600,"delay":0,"ttmEps":-1.052,"open":13.29,"prevYearClose":20.1,"prevWeekClose":13.02,"prevMonthClose":14.07,"prevQuarterClose":14.07,"fiveDayClose":12.68,"twentyDayClose":11.28,"sixtyDayClose":12.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07630\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"07630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07630\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1782403200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07630","date":"2026-10-15","current":-12.376426,"percent":0.607477,"low":-34.323153,"twenty":-29.852178,"median":-13.23402,"eighty":-10.652923,"high":-8.821219,"avg":-17.72259,"sd":8.718874,"marketCap":3657876813},"quantilePoints":[{"date":"2026-05-15","current":-32.36994,"twenty":-32.973318,"median":-32.357426,"eighty":-26.127101,"marketCap":11057651805},{"date":"2026-05-22","current":-30.548005,"twenty":-32.354923,"median":-30.958502,"eighty":-28.393426,"marketCap":10411425401},{"date":"2026-05-29","current":-32.218614,"twenty":-32.294393,"median":-30.958502,"eighty":-30.148817,"marketCap":11018988687},{"date":"2026-06-05","current":-29.849738,"twenty":-32.359929,"median":-31.257987,"eighty":-30.148817,"marketCap":10223633112},{"date":"2026-06-12","current":-29.369689,"twenty":-32.33377,"median":-30.548005,"eighty":-29.705347,"marketCap":10052410732},{"date":"2026-06-18","current":-29.78235,"twenty":-32.303072,"median":-30.338658,"eighty":-29.742668,"marketCap":10218109810},{"date":"2026-06-26","current":-29.297581,"twenty":-32.241427,"median":-30.11999,"eighty":-29.607619,"marketCap":10002701008},{"date":"2026-07-03","current":-16.26247,"twenty":-32.218614,"median":-29.994357,"eighty":-29.297581,"marketCap":5556442415},{"date":"2026-07-10","current":-15.780707,"twenty":-31.493905,"median":-29.916258,"eighty":-25.475578,"marketCap":5385220035},{"date":"2026-07-17","current":-11.297625,"twenty":-31.022068,"median":-29.816044,"eighty":-15.922995,"marketCap":3869073471},{"date":"2026-07-24","current":-9.271485,"twenty":-30.958502,"median":-29.609087,"eighty":-15.602668,"marketCap":3175898995},{"date":"2026-07-31","current":-10.646015,"twenty":-30.630104,"median":-29.369689,"eighty":-13.307417,"marketCap":3653664669},{"date":"2026-08-07","current":-10.047131,"twenty":-30.493855,"median":-29.24895,"eighty":-10.58915,"marketCap":3454825776},{"date":"2026-08-14","current":-10.299125,"twenty":-30.36699,"median":-25.475578,"eighty":-10.316459,"marketCap":3545960269},{"date":"2026-08-21","current":-10.772628,"twenty":-30.33128,"median":-16.418396,"eighty":-10.292557,"marketCap":3717182649},{"date":"2026-08-28","current":-12.490535,"twenty":-30.224959,"median":-15.896725,"eighty":-10.316459,"marketCap":4310937679},{"date":"2026-09-04","current":-14.62831,"twenty":-30.072679,"median":-15.691688,"eighty":-10.353511,"marketCap":4403575252},{"date":"2026-09-11","current":-12.087934,"twenty":-30.026033,"median":-14.57977,"eighty":-10.495083,"marketCap":3643753737},{"date":"2026-09-18","current":-12.193817,"twenty":-29.977617,"median":-13.665771,"eighty":-10.535977,"marketCap":3680473735},{"date":"2026-09-25","current":-12.65778,"twenty":-29.936332,"median":-13.862539,"eighty":-10.54718,"marketCap":3813230655},{"date":"2026-10-02","current":-13.309453,"twenty":-29.921275,"median":-13.342238,"eighty":-10.553476,"marketCap":4013778341},{"date":"2026-10-09","current":-11.861614,"twenty":-29.878786,"median":-13.325845,"eighty":-10.610057,"marketCap":3581612200},{"date":"2026-10-15","current":-12.092826,"twenty":-29.852178,"median":-13.23402,"eighty":-10.652923,"marketCap":3657876813}],"updateTime":1792418707824},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07630\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1119221642","title":"英派藥業-B：塞納帕利提交歐盟委員會，等待最終上市許可裁決","url":"https://stock-news.laohu8.com/highlight/detail?id=1119221642","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119221642?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 18:49","pubTimestamp":1789728550,"startTime":"0","endTime":"0","summary":"英派药业-B宣布，其核心候选药物塞纳帕利已正式向欧洲委员会提交申请，寻求获得最终的上市授权决定。英派药业正积极推进塞纳帕利的国际化布局，此次提交是其在全球范围内拓展肿瘤治疗版图的重要里程碑。后者将据此做出具有法律约束力的最终审批决定，涵盖该药物在全部欧盟成员国的上市许可。塞纳帕利作为一种高选择性PARP抑制剂，被视为英派药业最具潜力的在研资产之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132852174","title":"英派藥業與Pharmanovia宣佈：Senaparib獲歐洲藥監局人用藥品委員會積極意見，有望成為晚期高級別上皮性卵巢癌、輸卵管癌及原發性腹膜癌的一線維持治療新選擇","url":"https://stock-news.laohu8.com/highlight/detail?id=1132852174","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132852174?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 18:40","pubTimestamp":1789728014,"startTime":"0","endTime":"0","summary":"英派药业与其合作伙伴Pharmanovia近日联合宣布，欧洲药品管理局人用药品委员会已对Senaparib——一种极具潜力的PARP抑制剂——发布积极审评意见。这一关键进展，为该药物作为晚期高级别上皮性卵巢癌、输卵管癌及原发性腹膜癌患者的一线维持治疗，铺平了道路。倘若一切顺利获批，Senaparib有望为这些侵袭性癌症亚型的患者群体提供一种全新的治疗范式。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668191239","title":"港股午評|恒生指數早盤漲0.67%     AI製藥板塊大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2668191239","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668191239?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 12:00","pubTimestamp":1789704004,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数涨0.67%，涨164点，报24768点；恒生科技指数涨1.74%。港股早盘成交1070亿港元。十部门印发医药十五五规划，机构看好医药迎“Claude”时刻。AI制药进入战略入局阶段。曦智科技-P涨超17%。天数智芯涨超13%，公司有望持续受益AI资本开支的增长及算力自主可控浪潮。MINIMAX-W涨13%，旗下多款产品通过Singtel AI Pass纳入配套订阅计划。俊知集团涨超10%，收购青海中利光纤技术有望打开AI算力相关光纤产品增量空间。大股东解禁期满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0672654166.SGD","600547","LU0052756011.USD","BK1197","LU0828237940.HKD","LU1046422090.SGD","LU1366334578.USD","07630","LU0572940350.SGD","HK0000320264.USD","LU1267930227.SGD","IE0032431581.USD","LU0048580855.USD","80992","BK1193","BK1607","HHImain","BK1506","03419","07200","03417","03115","09067","00100","IE00B0JY6N72.USD","BK1576","LU0572939691.SGD","LU0791591158.USD","02833","LU1366334651.USD","LU0348827113.USD","HK0000306685.HKD","LU1808992512.USD","03032","01300","BK1592","LU0890818403.SGD","HSTECH","02800","LU1235295612.USD","LU0972618739.USD","09115","07226","LU0244354667.USD","LU1188198961.HKD","02837","03423","BK1149","BK1544","00992","300077","83115","02701","BK1583","LU0049112450.USD","07552","BK1163","LU0543330483.HKD","03696","LU0417516902.SGD","HK0000320223.HKD","BK1183","BK1161","06658","01787","LU0310800965.SGD","603127","82800","LNVGY","LU0791590937.USD","09088","LU0862451753.SGD","03067","LU0140636845.USD","LU0561508036.HKD","LU0320764755.SGD","02142","LU0463099449.HKD","LU0264606111.USD","HSI","07300","03037","01818","BK1141","09903","MCHmain","02656","LU1785774172.SGD","513600","BK1198","LU0348825331.USD","02670","BK1237","IE0034224299.USD","06127","07666","LU0029875118.USD","03033","03088","BK1117","HK0000306701.USD","LU0326950275.SGD","LU0181495838.USD","LU2242644610.SGD","07500","02228","IE0003895053.USD","TCHI","BK1526","LU0128525689.USD","LU0862451837.USD","LU0370786039.SGD","BK1574","LU0128522157.USD","01879","LU1831875114.USD","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668911592","title":"英派藥業-B早盤升逾20% 近期入通並獲高管增持公司普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668911592","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668911592?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 10:42","pubTimestamp":1789699320,"startTime":"0","endTime":"0","summary":"模拟交易客户端英派药业-B盘中涨超26%。截至发稿，股价上涨20.30%，现报13.57港元，成交额1.49亿港元。9月7日起，英派药业获纳入港股通名单。公司认为，获纳入沪港通及深港通将有利于进一步扩大公司的投资者基础，并有望提升公司H股的交易流动性。此外，公司执行董事兼首席执行官蔡遂雄近日于公开市场购买合共10万股公司普通股。塞纳帕利欧洲上市申请已获受理，预计2026年下半年获批。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-18/doc-inisfiik8576781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07630","SURE","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668196969","title":"港股異動 | 英派藥業-B(07630.HK)早盤升逾25% 近期入通並獲高管增持 核心產品塞納帕利加速放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2668196969","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668196969?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 10:01","pubTimestamp":1789696906,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668191987","title":"英派藥業－Ｂ(07630)股價上升8.156%，現價港幣$12.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2668191987","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668191987?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 09:45","pubTimestamp":1789695900,"startTime":"0","endTime":"0","summary":"[上升股]英派药业－Ｂ(07630) 股价在上午09:44比前收市价上升8.156%，现股价为港币$12.2。至目前为止，今日最高价为$12.2，而最低价为$11.3。总成交量为113.26万股，总成交金额为港币$1.327千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609181302/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609181302/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667963143","title":"英派藥業-B（07630）曾升逾20% 上周納入港股通 中期營收增長超3倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2667963143","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667963143?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 10:14","pubTimestamp":1789352048,"startTime":"0","endTime":"0","summary":"消息面上，公司H股已获纳入沪港通及深港通合资格证券名单，并自2026年9月7日起生效。根据此前英派药业公布的截至2026年6月30日止六个月中期业绩，期内收入达1.05亿元人民币，较去年同期的2520万元人民币大幅增长316.8%，主要来自核心产品塞纳帕利在中国的销售收入7040万元人民币及与Eikon Therapeutics合作协议的里程碑付款3480万元人民币。研发开支为9760万元人民币，主要用于塞纳帕利的欧洲药品管理局审查及早期候选药物的临床前研发。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991469","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","FLHK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667585631","title":"英派藥業－Ｂ(07630)股價大幅上升20.853%，現價港幣$15.59","url":"https://stock-news.laohu8.com/highlight/detail?id=2667585631","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667585631?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 09:35","pubTimestamp":1789349700,"startTime":"0","endTime":"0","summary":"[上升股]英派药业－Ｂ(07630) 股价在上午09:35比前收市价大幅上升20.853%，现股价为港币$15.59。至目前为止，今日最高价为$15.59，而最低价为$13.23。总成交量为336.88万股，总成交金额为港币$4.875千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260914279/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR260914279/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544308","title":"港股異動 | 英派藥業-B(07630.HK)尾盤升逾20% 公司本周進入港股通名單 塞納帕利入醫保後快速放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544308","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544308?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:31","pubTimestamp":1789111867,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666544991","title":"英派藥業－Ｂ(07630)股價大幅上升17.9%，現價港幣$13.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2666544991","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666544991?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 15:25","pubTimestamp":1789111500,"startTime":"0","endTime":"0","summary":"[上升股]英派药业－Ｂ(07630) 股价在下午03:24比前收市价大幅上升17.9%，现股价为港币$13.7。至目前为止，今日最高价为$13.7，而最低价为$10.7。总成交量为504.74万股，总成交金额为港币$6.014千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609111805/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609111805/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666629568","title":"英派藥業－Ｂ(07630)股價下跌5.024%，現價港幣$11.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2666629568","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666629568?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 14:24","pubTimestamp":1789021440,"startTime":"0","endTime":"0","summary":"[下跌股]英派药业－Ｂ(07630) 股价在下午02:23比前收市价下跌5.024%，现股价为港币$11.91。至目前为止，今日最高价为$12.87，而最低价为$11.91。总成交量为114.92万股，总成交金额为港币$1.42千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609102439/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609102439/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665339957","title":"英派藥業-B(07630)獲納入滬港通及深港通證券名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2665339957","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665339957?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:26","pubTimestamp":1788755188,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英派药业-B(07630)发布公告，根据上海证券交易所及深圳证券交易所分别发出的公告，公司H股已获纳入沪港通及深港通合资格证券名单，自2026年9月7日起生效。公司H股获纳入沪港通及深港通合资格证券名单后，中国内地合资格投资者将可透过上海证券交易所及深圳证券交易所直接投资公司H股。公司认为，获纳入沪港通及深港通将有利于进一步扩大公司的投资者基础，并有望提升公司H股的交易流动性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118211105","title":"英派藥業-B（07630）H股納入滬深港通合資格名單 將於2026年9月7日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1118211105","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118211105?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:11","pubTimestamp":1788754275,"startTime":"0","endTime":"0","summary":"南京英派药业股份有限公司9月7日发布自愿公告称，公司H股已被上海证券交易所及深圳证券交易所纳入沪港通及深港通合资格证券名单，生效日期为2026年9月7日。\\n\\n公告指出，H股被纳入相关名单后，中国内地合资格投资者可通过沪股通或深股通渠道直接买卖英派药业-B的H股。公司认为，这一安排有望扩大其投资者基础，并提升H股交易流动性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664319063","title":"英派藥業(07630)正式納入港股通 打開內地投資者參與通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2664319063","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664319063?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 20:05","pubTimestamp":1788523535,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，上交所9月4日盘后发布通知，根据《上海证券交易所沪港通业务实施办法》有关规定，英派药业(07630)正式调入港股通标的证券名单，该调整将于9月7日(周一)起生效。这意味着内地投资者自此可通过沪深港通直接买卖英派药业，正式解锁南向资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FLHK","07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184000576","title":"英派藥業-B發布2026年8月股份變動月報表，股本保持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1184000576","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184000576?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 16:48","pubTimestamp":1788511685,"startTime":"0","endTime":"0","summary":"2026年9月4日，英派药业-B（股票代码：07630）发布2026年8月股份变动月报表。公告显示，截至2026年8月31日，公司注册股本为人民币282,461,530元，股票类型为普通股H股，面值人民币1元。本月初和月末的已发行股份数均为282,461,530股，库藏股份为0股，股本总数未发生变化。\n公司同时披露，报告期内未进行新的股份发行、购回、注销或库藏股变动，也不存在任何股份期权、权证或可换股票据的行使或失效情形。截至期末，公司符合香港联交所相关上市规则的最低公众持股量要求。\n公告由执行董事兼首席执行官蔡遂雄签署，公司重申将继续严格遵守香港联交所《上市规则》及相关法律法规的各项规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163390150","title":"英派藥業-B：蔡遂雄增持，好倉比例升至6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=1163390150","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163390150?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:50","pubTimestamp":1788429032,"startTime":"0","endTime":"0","summary":"蔡遂雄于2026年9月1日以每股均价14.6105港元买入英派药业-B股份10.00万股，涉资约146.10万港元。蔡遂雄此次增持前持有英派药业-B好仓1844.09万股，占比6.53%；增持后持股量为1854.09万股，好仓比例升至6.56%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664982473","title":"港股異動 | 英派藥業-B(07630)漲近13% 核心產品塞納帕利快速放量 獲納入恒生綜指有望入通","url":"https://stock-news.laohu8.com/highlight/detail?id=2664982473","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664982473?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 15:07","pubTimestamp":1788419276,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英派药业-B涨近13%，截至发稿，涨11.14%，报14.87港元，成交额514.81万港元。消息面上，英派药业今早公告，董事会获公司执行董事兼首席执行官蔡遂雄告知，其近期已于公开市场购买合共10万股公司普通股，每股股份平均价格为约14.6105港元，占公司已发行股份总数之约0.035%。今年上半年，英派药业实现收入1.05亿元，同比增长316.8%；净亏损则同比收窄29.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","BK1161","07630","KCAI","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664184006","title":"英派藥業(07630.HK)首席執行官斥逾146萬元增持10萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664184006","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664184006?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 09:19","pubTimestamp":1788398340,"startTime":"0","endTime":"0","summary":"英派药业(07630.HK) 公布，执行董事兼首席执行官蔡遂雄近日于公开市场购入合共10万股公司普通股，占已发行股份总数约0.035%，每股平均价格约14.6105元，涉资146.1万元。紧随增持后，蔡氏合共持有约1,854.09万股，占已发行股本总额约6.564%。(gc/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260508093246116_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260508093246116_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542671/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542671/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664703842","title":"英派藥業-B(07630.HK)獲執行董事兼首席執行官蔡遂雄增持10萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664703842","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664703842?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 08:09","pubTimestamp":1788394151,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121979207","title":"英派藥業-B（07630）CEO蔡遂雄增持10萬股 持股比例升至6.564%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121979207","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121979207?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 08:06","pubTimestamp":1788393971,"startTime":"0","endTime":"0","summary":"南京英派药业股份有限公司（英派药业-B，07630）9月3日自愿公告称，执行董事兼首席执行官蔡遂雄博士近期在公开市场合计买入100,000股公司普通股，每股平均价格约14.6105港元，增持股份占公司已发行股份总数约0.035%。\\n\\n本次增持后，蔡遂雄博士合共持有18,540,884股公司股份，占截至公告日期已发行股本总额约6.564%。\\n\\n公告指出，蔡遂雄博士对公司整体发展前景及潜在增长保持信心，并在遵守适用法律及监管规定的前提下，不排除未来继续增持股份的可能性。\\n\\n公司提醒股东及潜在投资者在买卖公司证券时保持审慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":123,"code":"91000000","status":"200"}]}}